Delivery Order SPE2DB22D3016-SPE2DB25FBEW3
- Not listed
- The Defense Logistics Agency awarded a $26,021.15 delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 vaccines in 0.5 mL syringe format on July 22, 2025, with ultimate completion scheduled for July 23, 2025. This is a firm fixed price, non-set-aside contract with performance at the company's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $19,605.24 to AmerisourceBergen Drug Corp for the supply of Prevnar 20 vaccine in 0.5mL syringes. This firm fixed-price delivery order, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a non-competitive award under the company's existing contract vehicle. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and...
- The Defense Logistics Agency awarded a $6,752.85 delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in 0.5mL syringes. This competitively awarded, firm fixed price contract has a completion date of September 4, 2025, and represents a child order under AmerisourceBergen's broader pharmaceutical supply framework with DLA. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and...
- The Defense Logistics Agency awarded a $36,998.71 firm fixed price delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in 0.5mL syringes. This non-competitive delivery order, issued on September 12, 2025, with an ultimate completion date of September 15, 2025, represents a routine pharmaceutical procurement fulfilling ongoing federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor within the...
- The Defense Logistics Agency awarded a delivery order valued at $12,735.59 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 vaccine in 0.5mL syringes. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of June 3, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued...
- The Defense Logistics Agency awarded a $19,229.47 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 vaccine in 0.5ML syringes under contract number 4568915768. The award was made on July 28, 2025, with an ultimate completion date of July 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This is a non-set-aside, competitively awarded delivery order issued under the company's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,535.12 for PREVNAR 20 Syringe 0.5ML on July 11, 2025, with completion scheduled for July 14, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single-line pharmaceutical procurement under the company's broader relationship...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in 0.5 mL syringe format, with a ceiling value of $21,643.56. This firm fixed price, non-set-aside contract was competitively awarded on April 24, 2025, with an ultimate completion date of April 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a continuation of the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of PREVNAR 20 syringe vaccines (0.5mL) valued at $30,403.64. This firm fixed-price delivery order represents a non-set-aside competitive award with an ultimate completion date of August 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (SPE2DX) with...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on May 8, 2025, valued at $21,820.23 for the supply of PREVNAR 20 vaccine in 0.5 mL syringes. This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of May 9, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a relatively small transaction within...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBEW3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $23,429.21 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 vaccine in 0.5mL syringes. This non-competitive, firm fixed-price delivery order was awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine procurement under the company's larger relationship with the federal government for pharmaceutical and medical supply distribution to defense and military healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its comprehensive global pharmaceutical support vehicle. The company's award demonstrates its ongoing role as a primary supplier of vaccines, medications, and medical supplies essential to military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.4k | 8/13/25 |